115 related articles for article (PubMed ID: 16008893)
1. [Management and prognosis of metastatic ovarian carcinoma from nongenital tract].
Wu XF; Chen Y
Zhonghua Fu Chan Ke Za Zhi; 2005 Jun; 40(6):404-6. PubMed ID: 16008893
[TBL] [Abstract][Full Text] [Related]
2. The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries.
Ayhan A; Guvenal T; Salman MC; Ozyuncu O; Sakinci M; Basaran M
Gynecol Oncol; 2005 Aug; 98(2):235-41. PubMed ID: 15982725
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathological features and prognosis of 68 patients with metastatic ovarian tumors from the gastric cancer].
Zhao JZ; Wang G; Zhang RP; Liang H
Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Feb; 13(2):129-32. PubMed ID: 20186624
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis and treatment of recurrent epithelial ovarian carcinoma].
Wu XF; Chen HZ; Han DF
Zhonghua Fu Chan Ke Za Zhi; 2003 Nov; 38(11):664-6. PubMed ID: 14728851
[TBL] [Abstract][Full Text] [Related]
5. Cytoreductive surgery for stage IV epithelial ovarian cancer.
Zang RY; Zhang ZY; Cai SM; Li ZT; Chen J; Tang MQ; Liu Q
J Exp Clin Cancer Res; 1999 Dec; 18(4):449-54. PubMed ID: 10746968
[TBL] [Abstract][Full Text] [Related]
6. Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results.
Tserkezoglou A; Kontou S; Hadjieleftheriou G; Apostolikas N; Vassilomanolakis M; Sikiotis K; Salamalekis E; Tseke P; Magiakos G
Anticancer Res; 2006; 26(3B):2339-44. PubMed ID: 16821613
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant intraarterial chemotherapy and embolization in treatment of advanced ovarian epithelial carcinoma.
Liu EL; Mi RR
Chin Med J (Engl); 2004 Oct; 117(10):1547-51. PubMed ID: 15498381
[TBL] [Abstract][Full Text] [Related]
8. The role of secondary cytoreductive surgery for recurrent mucinous epithelial ovarian cancer (mEOC).
Cheng X; Jiang R; Li ZT; Tang J; Cai SM; Zhang ZY; Tian WJ; Zang RY
Eur J Surg Oncol; 2009 Oct; 35(10):1105-8. PubMed ID: 19443175
[TBL] [Abstract][Full Text] [Related]
9. Incidence of metastasis to the ovaries from nongenital tract primary tumors.
Moore RG; Chung M; Granai CO; Gajewski W; Steinhoff MM
Gynecol Oncol; 2004 Apr; 93(1):87-91. PubMed ID: 15047218
[TBL] [Abstract][Full Text] [Related]
10. [How to increase the optimal rate of secondary cytoreductive surgery in recurrent epithelial ovarian cancer].
Li YF; Li MD; Liu FY; Liu JH; Li JD
Ai Zheng; 2003 Nov; 22(11):1193-6. PubMed ID: 14613651
[TBL] [Abstract][Full Text] [Related]
11. The role of cytoreductive surgery for colon cancer metastatic to the ovary.
McCormick CC; Giuntoli RL; Gardner GJ; Schulick RD; Judson K; Ronnett BM; Vang R; Bristow RE
Gynecol Oncol; 2007 Jun; 105(3):791-5. PubMed ID: 17408727
[TBL] [Abstract][Full Text] [Related]
12. Role of salvage cytoreductive surgery in the treatment of patients with recurrent ovarian cancer after platinum-based chemotherapy.
Matsumoto A; Higuchi T; Yura S; Mandai M; Kariya M; Takakura K; Fujii S
J Obstet Gynaecol Res; 2006 Dec; 32(6):580-7. PubMed ID: 17100820
[TBL] [Abstract][Full Text] [Related]
13. Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer.
Zang RY; Zhang ZY; Li ZT; Cai SM; Tang MQ; Chen J; Liu Q
Eur J Surg Oncol; 2000 Dec; 26(8):798-804. PubMed ID: 11087649
[TBL] [Abstract][Full Text] [Related]
14. Primary cytoreductive surgery for epithelial ovarian cancer.
Hacker NF; Berek JS; Lagasse LD; Nieberg RK; Elashoff RM
Obstet Gynecol; 1983 Apr; 61(4):413-20. PubMed ID: 6828269
[TBL] [Abstract][Full Text] [Related]
15. [Cytoreductive surgery in the management of stage IV epithelial ovarian cancer].
Zang R; Zhang Z; Chen J
Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):197-9. PubMed ID: 11776157
[TBL] [Abstract][Full Text] [Related]
16. Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients.
Colombo PE; Mourregot A; Fabbro M; Gutowski M; Saint-Aubert B; Quenet F; Gourgou S; Rouanet P
Eur J Surg Oncol; 2009 Feb; 35(2):135-43. PubMed ID: 18289825
[TBL] [Abstract][Full Text] [Related]
17. Ovarian metastases from breast cancer: report of 29 cases.
Bigorie V; Morice P; Duvillard P; Antoine M; Cortez A; Flejou JF; Uzan S; Darai E; Barranger E
Cancer; 2010 Feb; 116(4):799-804. PubMed ID: 20041486
[TBL] [Abstract][Full Text] [Related]
18. [Factors affecting disease recurrence and the role of secondary therapies in the management for patients with recurrent ovarian carcinoma].
Zang R; Zhang Z; Cai S
Zhonghua Fu Chan Ke Za Zhi; 2002 Sep; 37(9):546-9. PubMed ID: 12411017
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients.
Vergote I; De Wever I; Tjalma W; Van Gramberen M; Decloedt J; van Dam P
Gynecol Oncol; 1998 Dec; 71(3):431-6. PubMed ID: 9887245
[TBL] [Abstract][Full Text] [Related]
20. Impact of second look laparotomy and secondary cytoreductive surgery at second-look laparotomy in ovarian cancer patients.
Obermair A; Sevelda P
Acta Obstet Gynecol Scand; 2001 May; 80(5):432-6. PubMed ID: 11328220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
